SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-150438
Filing Date
2024-05-30
Accepted
2024-05-30 16:44:37
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d804432ds3.htm S-3 170511
2 EX-5.1 d804432dex51.htm EX-5.1 8209
3 EX-23.1 d804432dex231.htm EX-23.1 1798
4 EX-FILING FEES d804432dexfilingfees.htm EX-FILING FEES 31983
5 GRAPHIC g804432dsp30.jpg GRAPHIC 3766
6 GRAPHIC g804432dsp30a.jpg GRAPHIC 15703
7 GRAPHIC g804432g40f77.jpg GRAPHIC 52056
  Complete submission text file 0001193125-24-150438.txt   312497
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279833 | Film No.: 241006176
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)